Authors


Camille Smith, PharmD, DPLA, CCRP

Latest:

Review of 3 Alternative Pathways to Access Non–FDA-Approved Drugs

Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.


Stephen Eng, PharmD, BCOP

Latest:

New Therapy for Chronic Graft-Vs-Host Disease: Axatilimab

Axatilimab is a colony-stimulating factor-1 receptor–blocking monoclonal antibody indicated after 2 lines of systemic therapy.


Katherine E. Taylor, PharmD, MBA, BCOP

Latest:

How Pharmacists Can Make an Impact When Treating Dedifferentiated Liposarcoma With Brigimadlin

Brigimadlin is a new oral MDM2-p53 antagonist under investigation as a potential first-line therapy to improve outcomes for patients with advanced or metastatic dedifferentiated liposarcoma.


J. Corey Feist, JD, MBA

Latest:

Breaking Down Barriers to Care and Transforming Pharmacy Professionals’ Mental Health

Pharmacy professionals deserve the right to pursue mental health care without fear of losing their jobs. The Wellbeing First Champion Challenge is helping change this.


Sarah Palacio, PharmD, BCPS, BCACP, CPP

Latest:

Pharmacist-Led DOAC Monitoring Improves Dosing

Patient monitoring significantly improved for patients seen in the pharmacist-led clinic due to greater efforts to order labs per policy and prescribe an appropriate DOAC dose.




Bobby Gjorseski, PharmD, RPh

Latest:

Respiratory Syncytial Virus in Older Adults: Research Insights and Recommendations

Although RSV has long been associated with infants and young children, research demonstrates that it is also a significant health risk for adults over the age of 60.


Gabriella Scala

Latest:

Case Studies: May 2022

How would you handle these patients' questions?


Ramzan Judge, PharmD, BCCCP

Latest:

Dispensing Medication for Muslims: A Guide for Pharmacists

Despite Muslim patients’ need for halal medication, more than 80% of pharmacists were found to lack knowledge about where to look to find alternative medications that are halal.


Rachit Thariani

Latest:

Why Data Point to Hospital At-Home Care as Next Evolution of Clinical Medicine

With health systems undergoing a necessary reevaluation of how they allocate their funding into the future, initial data support the need for them to offer a hospital-at-home option for patients they serve.


Jeffrey R. Suchard, MD, FACEP, FACMT

Latest:

Insecticide Misuse With Cannabinoids and Its Resulting Complications: A Case Report

The use of adulterated cannabinoids mixed with insecticides is becoming more common.


Samuel Schauer, PharmD Candidate

Latest:

Considerations for Environmentally Conscious Pharmacy Students

Environmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.


Brook Kotlatz, PharmD Candidate

Latest:

Learning in Lockdown: Adapting a Reproductive Health Campaign for Pandemic Life

Although COVID-19 paused our original plans, we were ultimately able to reach more people than we ever could have via in-person presentations alone.


Greta Staubly

Latest:

Oncology Overview: Pirtobrutinib—A New BTK Inhibitor

Pirtobrutinib is under investigation in clinical trials in patients with CLL/small lymphocytic lymphoma, mantle cell lymphoma, and non-Hodgkin lymphoma.


Christina M. Madison, PharmD, FCCP, AAHIVP

Latest:

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

In this episode of Public Health Matters, Christina Madison discusses the concept of reproductive justice and ensuring Black maternal health efforts are not left behind with Regina Davis Moss of In Our Own Voice.


Stephen Lee, PharmD, BCPS, BCCCP

Latest:

Insecticide Misuse With Cannabinoids and Its Resulting Complications: A Case Report

The use of adulterated cannabinoids mixed with insecticides is becoming more common.


Matt Merical, PharmD Candidate

Latest:

Student Advocacy and Its Impact on Tobacco Cessation Programs

Because pharmacists are one of the most accessible health care providers, we are trained in medication selection and in how to counsel patients who wish to stop smoking.


Marina Dykhne PharmD, BCACP, APh, CDCES

Latest:

Case Study: Insulin Sensitizers as Enhancers in Diabetes Management

The objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.


Jessica Davis, PharmD, BCOP

Latest:

Expanding Roles for Pharmacy Technicians in Ambulatory Oncology

Jessica Davis, PharmD, BCOP highlights the role of pharmacy technicians in ambulatory oncology clinic settings.


Jeffrey Swanson

Latest:

Can Pharmacy Automation Help Solve the Industry’s Labor Shortage?

As staffing pressures continue straining pharmacy operations, the right automation solutions offer a path to driving growth and maintaining safety standards, all while better utilizing current personnel.


Manuel Cortez, PharmD, BCOP

Latest:

Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing Sarcoma

This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.


Kristen Schaeffler, PharmD, MHA

Latest:

ChatRx: Responsible AI Use for Clinical Pharmacists

Pharmacists, in particular, must be cautious and deliberate in using ChatGPT to ensure that its benefits are fully realized while minimizing risk and misinformation.


Beth Richter, PharmD

Latest:

The Power of Integrated Data Feeds to Support Drug Diversion Detection

A centralized, artificial intelligence–driven approach can integrate diverse data and foster multidisciplinary collaboration.


Tanjia Toma, PharmD Candidate

Latest:

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.


Scotty Reams, PharmD

Latest:

Kevin’s Law Makes 72-Hour Supply of More Medication Available to Patients

Eighteen states have enacted legislation that allows pharmacists to help patients when providers are not reachable.



Emily M Persson, PharmD

Latest:

Direct Oral Anticoagulant Use for Left Ventricular Thrombus Treatment

An overview of the use of direct oral anticoagulants as an alternative to warfarin in the treatment of left ventricular thrombus.


Neil Palmisiano, MD, MS

Latest:

Novel Immunotherapy in Up-front Setting Shows Improved Outcomes in ALL

Study data demonstrate large step forward for this patient population